USANA Health Sciences, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended July 01, 2023
July 25, 2023 at 04:05 pm EDT
Share
USANA Health Sciences, Inc. reported earnings results for the second quarter and six months ended July 01, 2023. For the second quarter, the company reported sales was USD 238.2 million compared to USD 264.47 million a year ago. Net income was USD 17.29 million compared to USD 19.16 million a year ago. Diluted earnings per share from continuing operations was USD 0.89 compared to USD 1 a year ago.
For the six months, sales was USD 486.56 million compared to USD 537.34 million a year ago. Net income was USD 35.68 million compared to USD 41.63 million a year ago. Diluted earnings per share from continuing operations was USD 1.84 compared to USD 2.15 a year ago.
USANA Health Sciences, Inc. is a global direct-selling, personal health and wellness company that develops and manufactures science-based nutritional and personal care products. The Company operates through one segment: Direct-selling. Its two geographic regions include Asia Pacific, and Americas and Europe. The Companyâs product lines include USANA Nutritionals Optimizers, Essentials/CellSentials, foods, personal care, skin care, and all others. The USANA Nutritionals Optimizers consist of supplements designed to meet individual health and nutritional needs. The Essentials/CellSentials product line includes vitamin and mineral supplements that provide total body nutrition. Its food product line includes meal replacement shakes, snack bars, and other related products. It also offers products designed for prenatal, infant, and young-child age groups in China. It distributes products internationally through direct selling, which entails person-to-person marketing and selling of products.
USANA HEALTH SCIENCES, INC. 
